MDS-280: Longer-Term RBC Transfusion Reduction in the Phase 3 MEDALIST Study of Luspatercept in Patients with Lower-Risk MDS (LR-MDS) with Ring Sideroblasts (RS)
Year: 2020
Type: conference-abstract
Authors: Rami S. Komrokji, Mikkael A. Sekeres, Amer M. Zeidan, Pierre Fenaux, Uwe Platzbecker, Amy E. DeZern, Peter L. Greenberg, Michael R. Savona, Joseph G. Jurcic, Amit Verma, Ghulam J. Mufti, Rena Buckstein, Valeria Santini, Abderrahmane Laadem, Rodrigo Ito, Jennie Zhang, Chrystal U. Louis, Peter G. Linde, Guillermo Garcia-Manero
Institutions: Moffitt Cancer Center, Cleveland Clinic, Yale Cancer Center, Yale University, Hôpital Saint-Louis, Université Paris Diderot, University Hospital Leipzig, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Stanford University, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center, King's College London, Sunnybrook Health Science Centre, Sunnybrook Hospital, Odette Cancer Centre, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Bristol-Myers Squibb (United States), Acceleron Pharma (United States), The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3112988389